Diagnostic value spectropolarimetry of blood plazma in patients with sporadic and family breast cancer

机译：散发性和家族性乳腺癌患者血浆血浆的诊断价值

获取原文

页面导航

摘要
著录项
相似文献
相关主题

摘要

The aim was to study the possibility of using polarimetry methods of performance evaluation of blood plasma of patients with breast cancer and spectroscopy method in the diagnosis of breast cancer and determine the criteria for their use of non-invasive screening for problems.

机译：目的是研究使用极化测定法对乳腺癌患者的血浆性能进行评估的可能性和光谱法在乳腺癌的诊断中的可能性，并确定使用无创性筛查问题的标准。

著录项

来源
《International conference on correlation optics》|2013年|906623.1-906623.8|共8页
会议地点
作者
O.P. Peresunko; T.V. Kruk; S.B. Yermolenko;
展开▼
作者单位

展开▼
会议组织
原文格式 PDF
正文语种
中图分类
关键词
polarimetry; spectropolatimetry; blood plasma; breast cancer;

机译：旋光法分光计时血浆;乳腺癌;

相似文献

外文文献
中文文献
专利

1. BRCA1/2 mutation screening in high-risk breast/ovarian cancer families and sporadic cancer patient surveilling for hidden high-risk families [J] . Dace Berzina, Miki Nakazawa-Miklasevica, Jekaterina Zestkova, BMC Medical Genetics . 2013,第1期

机译：高危乳腺癌/卵巢癌家庭的BRCA1 / 2突变筛查以及针对隐藏的高危家庭的零星癌症患者进行监测
2. Comparison of clinicopathological features and outcome of breast cancer in BRCA-mutation carriers, in patients with a family history without BRCA-mutation and in patients with sporadic disease [J] . Intelligence: A Multidisciplinary Journal . 2020,第期

机译：BRCA - 突变携带者乳腺癌临床病理特征和结果的比较，在没有BRCA - 突变的家族史和散发性疾病患者的患者中
3. Limited family structure and triple-negative breast cancer (TNBC) subtype as predictors of BRCA mutations in a genetic counseling cohort of early-onset sporadic breast cancers [J] . ZugazagoitiaJ., Pérez-SeguraP., ManzanoA., Breast cancer research and treatment. . 2014,第2期

机译：有限的家庭结构和三阴性乳腺癌（TNBC）亚型可预测早发性散发性乳腺癌的遗传咨询队列中BRCA突变
4. Diagnostic value spectropolarimetry of blood plazma in patients with sporadic and family breast cancer [C] . O.P. Peresunko, T.V. Kruk, S.B. Yermolenko International conference on correlation optics . 2013

机译：散发性和家庭乳腺癌患者血浆的诊断价值分光极
5. Association between use of a specialized diagnostic assessment unit and the diagnostic interval in Ontario breast cancer patients. [D] . Jiang, Li. 2014

机译：安大略省乳腺癌患者使用专门的诊断评估单位与诊断间隔之间的关联。
6. BRCA1/2 mutation screening in high-risk breast/ovarian cancer families and sporadic cancer patient surveilling for hidden high-risk families [O] . Dace Berzina, Miki Nakazawa-Miklasevica, Jekaterina Zestkova, 2013

机译：高危乳腺癌/卵巢癌家庭的BRCA1 / 2突变筛查以及针对隐藏的高危家庭的零星癌症患者进行监测
7. BRCA1/2 mutation screening in high-risk breast/ovarian cancer families and sporadic cancer patient surveilling for hidden high-risk families [O] . Dace Berzina, Miki Nakazawa-Miklasevica, Jekaterina Zestkova, 2013

机译：高危乳腺癌/卵巢癌家庭的BRCA1 / 2突变筛查以及针对隐藏的高危家庭的零星癌症患者进行监测
8. Development of a Diagnostic Blood Test for Breast Cancer [R] . Gabrielson, E. W. 2003

机译：乳腺癌诊断血液检测的开发

Diagnostic value spectropolarimetry of blood plazma in patients with sporadic and family breast cancer

摘要

著录项

相似文献

相关主题

期刊订阅